+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "T Cell Therapies"

Strategic Intelligence: Immuno-oncology (2025) - Product Thumbnail Image

Strategic Intelligence: Immuno-oncology (2025)

  • Report
  • July 2025
  • 163 Pages
  • Global
From
From
From
From
From
From
From
From
Cell Therapy Market Report and Forecast 2025-2034 - Product Thumbnail Image

Cell Therapy Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Biotechnology Market Report and Forecast 2025-2034 - Product Thumbnail Image

Biotechnology Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
T-Cell Immunotherapy Landscape - Product Thumbnail Image

T-Cell Immunotherapy Landscape

  • Report
  • April 2025
  • 43 Pages
  • Global
From
Autologous Cell Therapy Market Report and Forecast 2025-2034 - Product Thumbnail Image

Autologous Cell Therapy Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 350 Pages
  • Global
From
Genomics Market Report and Forecast 2025-2034 - Product Thumbnail Image

Genomics Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
From
Innovation Insights: Cell Therapy for Autoimmune diseases - Product Thumbnail Image

Innovation Insights: Cell Therapy for Autoimmune diseases

  • Report
  • January 2025
  • 50 Pages
  • Global
From
Innovation Insights: B-cell Depletion - Product Thumbnail Image

Innovation Insights: B-cell Depletion

  • Report
  • December 2024
  • 55 Pages
  • Global
From
Loading Indicator

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease. T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more